Plasma Cell Neoplasm
📧 Sign up to get email alerts when something new happens for Plasma Cell Neoplasm.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-11-30Clinical Trial Update: Antithymocyte Globulin in Treating Patients Undergoing Stem Cell Transplant for Multiple Myeloma [Phase 2]
Phase 2 trial evaluating antithymocyte globulin (Thymoglobulin) in patients undergoing stem cell transplantation for multiple myeloma has co…
-
CLINICAL_TRIALS trial_result · 2011-11-17Clinical Trial Update: Total-Body Irradiation, Busulfan, and Interferon Alfa Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Multiple Myeloma [Phase 2]
Phase 2 trial evaluating a conditioning regimen of total-body irradiation, busulfan, and interferon alfa before peripheral stem cell or bone…
-
CLINICAL_TRIALS trial_result · 2011-09-01Clinical Trial Update: Ice Chips or Saline Mouth Rinse in Reducing or Preventing Mucositis in Patients Receiving Melphalan and Autologous Stem Cell Transplant for Multiple Myeloma [NA]
A completed clinical trial evaluated whether ice chips or saline mouth rinse can reduce or prevent mucositis in multiple myeloma patients un…
-
CLINICAL_TRIALS trial_result · 2011-08-03Clinical Trial Update: PS-341 in Treating Patients With Advanced Cancer [Phase 1]
Phase 1 study of PS-341 (bortezomib) in patients with advanced cancer has completed, including leukemia and lymphoma cohorts among the liste…
-
CLINICAL_TRIALS trial_result · 2011-07-27Clinical Trial Update: Lenalidomide, Cyclophosphamide, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma [Phase 2]
Phase 2 trial evaluating a three-drug regimen of lenalidomide, cyclophosphamide, and dexamethasone in newly diagnosed multiple myeloma; resu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-07-15Clinical Trial Update: Sirolimus, Tacrolimus, and Methotrexate in Preventing Acute Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation [Phase 1, Phase 2]
A completed Phase 1/2 trial evaluated sirolimus, tacrolimus, and methotrexate to prevent acute graft-versus-host disease in patients with he…
-
CLINICAL_TRIALS trial_result · 2011-06-23Clinical Trial Update: Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma [Phase 2]
Phase 2 clinical trial evaluating combination chemotherapy followed by bone marrow or peripheral stem cell transplantation in patients with …
-
CLINICAL_TRIALS trial_result · 2011-05-16Clinical Trial Update: Everolimus in Treating Patients With Relapsed or Refractory Multiple Myeloma [Phase 2]
Phase 2 trial of everolimus in relapsed or refractory multiple myeloma has completed; results are reported.
-
CLINICAL_TRIALS trial_result · 2011-05-16Clinical Trial Update: Interferon-gamma or Aldesleukin and Vaccine Therapy in Treating Patients With Multiple Myeloma [Phase 2]
A Phase 2 trial evaluating interferon-gamma or aldesleukin in combination with vaccine therapy for multiple myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2011-05-11Clinical Trial Update: High-Dose Melphalan, Total-Body Irradiation, and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma in First Relapse [Phase 2]
A Phase 2 study evaluating high-dose melphalan with total-body irradiation followed by peripheral stem cell transplantation for patients wit…
-
CLINICAL_TRIALS trial_result · 2011-05-11Clinical Trial Update: Bevacizumab in Treating Patients With Relapsed or Refractory Multiple Myeloma [Phase 2]
Bevacizumab was studied in a Phase 2 trial for relapsed or refractory multiple myeloma; the study has completed.
-
CLINICAL_TRIALS trial_result · 2011-05-11Clinical Trial Update: Samarium Sm 153 Lexidronam Pentasodium and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma [Phase 1, Phase 2]
A Phase 1/2 clinical trial update evaluating the combination of Samarium-153 lexidronam pentasodium and bortezomib in relapsed or refractory…
-
CLINICAL_TRIALS trial_result · 2010-10-18Clinical Trial Update: Anti-thymocyte Globulin and Melphalan in Treating Patients With Relapsed Multiple Myeloma [Phase 2]
Phase 2 trial evaluating anti-thymocyte globulin plus melphalan in relapsed multiple myeloma was terminated. Results were posted in 2010.
-
CLINICAL_TRIALS trial_result · 2010-10-01Clinical Trial Update: High-Dose Melphalan Followed by Peripheral Stem Cell Transplant in Treating Patients With Amyloidosis [Phase 2]
Phase 2 clinical trial evaluating high-dose melphalan followed by peripheral stem cell transplantation in patients with amyloidosis. The stu…
-
CLINICAL_TRIALS trial_result · 2010-09-21Clinical Trial Update: Melphalan With or Without Holmium Ho 166 DOTMP Followed by Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma [Phase 3]
A Phase 3 clinical trial comparing melphalan with or without Holmium-166 DOTMP, followed by peripheral stem cell transplantation, in patient…
-
CLINICAL_TRIALS trial_result · 2010-09-21Clinical Trial Update: Melphalan and Busulfan Followed By Donor Peripheral Stem Cell Transplant, Tacrolimus, and Methotrexate in Treating Patients With Multiple Myeloma [Phase 2]
A Phase 2 trial evaluating melphalan and busulfan conditioning followed by donor peripheral stem cell transplantation with tacrolimus and me…
-
CLINICAL_TRIALS trial_result · 2010-09-21Clinical Trial Update: Radiation Therapy Using Holmium Ho 166 DOTMP Plus Melphalan and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial evaluating Holmium-166 DOTMP plus Melphalan and peripheral stem cell transplantation in patients with m…
-
CLINICAL_TRIALS trial_result · 2010-06-11Clinical Trial Update: O6-benzylguanine And Carmustine in Treating Patients With Multiple Myeloma [Phase 2]
Phase II trial evaluating the combination of O6-benzylguanine and carmustine in patients with multiple myeloma. The study has completed.
-
CLINICAL_TRIALS trial_result · 2010-03-10Clinical Trial Update: MS-275 in Treating Patients With Hematologic Cancer [Phase 1]
A Phase 1 trial of MS-275 (entinostat) in patients with hematologic cancers, including leukemia, multiple myeloma/plasma cell neoplasms, and…
-
CLINICAL_TRIALS trial_result · 2010-03-10Clinical Trial Update: Cyclophosphamide Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancer [Phase 1]
Phase 1 trial of cyclophosphamide followed by bone marrow transplantation for hematologic cancers has completed.
-
CLINICAL_TRIALS trial_result · 2009-04-03Clinical Trial Update: Chemotherapy, Holmium Ho 166 DOTMP, and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma [Phase 1, Phase 2]
This document reports on a Phase 1/2 clinical trial evaluating Holmium-166 DOTMP chemotherapy combined with peripheral stem cell transplanta…